We are live on ! Find out more
PLC

Peapod Lane Capital Portfolio holdings

AUM $148M
1-Year Est. Return 89.92%
This Fund
S&P 500
This Quarter Est. Return
+9.94%
1 Year Est. Return
+89.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$122M
AUM Growth
+$4.36M
Cap. Flow
-$1.05M
Cap. Flow %
-0.86%
Top 10 Hldgs %
30.92%
Holding
68
New
9
Increased
32
Reduced
20
Closed
6

Top Buys

Rank Stock Value
1
LAB icon
Standard BioTools
LAB
+$2.46M
2
SEG
Seaport Entertainment Group
SEG
+$1.93M
3
ARQ icon
Arq
ARQ
+$1.75M
4
KELYA icon
Kelly Services Class A
KELYA
+$1.62M
5
INGN icon
Inogen
INGN
+$1.6M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$4.86M
2
ANRO icon
Alto Neuroscience
ANRO
+$4.52M
3
BH icon
Biglari Holdings Class B
BH
+$4.12M
4
ALTO icon
Alto Ingredients
ALTO
+$2.66M
5
CLYM
Climb Bio
CLYM
+$2.64M

Sector Composition

Rank Sector Weight
1 Healthcare 20.82%
2 Industrials 20.45%
3 Consumer Discretionary 16.52%
4 Consumer Staples 9.77%
5 Real Estate 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPI icon
26
Intrepid Potash
IPI
$468M
$2M 1.64%
46,086
– –
ARQ icon
27
Arq
ARQ
$91M
$1.97M 1.62%
775,349
+546,785
+239% +$1.75M
SEG
28
Seaport Entertainment Group
SEG
$359M
$1.97M 1.62%
+92,506
New +$1.93M
RGP icon
29
Resources Connection
RGP
$147M
$1.96M 1.61%
528,411
+169,457
+47% +$694K
UEIC icon
30
Universal Electronics
UEIC
$66.1M
$1.88M 1.54%
455,491
-52
-0% -$206
LAB icon
31
Standard BioTools
LAB
$315M
$1.86M 1.53%
+2,028,527
New +$2.46M
ALTO icon
32
Alto Ingredients
ALTO
$351M
$1.82M 1.49%
406,385
-837,813
-67% -$2.66M
GAIA icon
33
Gaia
GAIA
$47.6M
$1.74M 1.43%
630,795
-45
-0% -$148
TWIN icon
34
Twin Disc
TWIN
$342M
$1.62M 1.33%
108,107
-30,523
-22% -$516K
INGN icon
35
Inogen
INGN
$163M
$1.59M 1.31%
+258,645
New +$1.6M
PLRX icon
36
Pliant Therapeutics
PLRX
$64.4M
$1.59M 1.3%
1,288,578
+402,204
+45% +$508K
TUSK icon
37
Mammoth Energy Services
TUSK
$165M
$1.51M 1.24%
+599,805
New +$1.37M
KELYA icon
38
Kelly Services Class A
KELYA
$530M
$1.51M 1.24%
+169,949
New +$1.62M
AVIR icon
39
Atea Pharmaceuticals
AVIR
$406M
$1.44M 1.18%
272,820
-162,200
-37% -$745K
CLAR icon
40
Clarus
CLAR
$147M
$1.43M 1.17%
530,871
+65,678
+14% +$215K
NKTX icon
41
Nkarta
NKTX
$168M
$1.41M 1.15%
676,212
+13
+0% +$29
HYNE
42
Hoyne Bancorp
HYNE
$121M
$1.4M 1.14%
96,688
+26,193
+37% +$378K
INVE icon
43
Identive
INVE
$62.9M
$1.38M 1.13%
376,730
-4
-0% -$13
WHG icon
44
Westwood Holdings Group
WHG
$189M
$1.3M 1.06%
78,859
-9,821
-11% -$167K
AXR icon
45
AMREP Corp
AXR
$120M
$1.28M 1.05%
46,062
-2
-0% -$47
ALOT icon
46
AstroNova
ALOT
$226M
$1.21M 0.99%
130,978
+9,595
+8% +$87.7K
FBLA
47
FB Bancorp
FBLA
$250M
$1.21M 0.99%
88,198
+17,769
+25% +$234K
NTIC icon
48
Northern Technologies International Corp
NTIC
$77.8M
$1.18M 0.97%
142,642
+21
+0% +$185
LSBK icon
49
Lake Shore Bancorp
LSBK
$135M
$1.05M 0.86%
68,943
+21
+0% +$321
LAKE icon
50
Lakeland Industries
LAKE
$120M
$1.03M 0.85%
128,118
+59,795
+88% +$539K
1
2
3

Similar funds

AWA
Authentikos Wealth Advisory Morgan Hill, California $148M AUM 9.86% 1-Year Est. Return
MM
MQS Management New York $148M AUM 0.73% 1-Year Est. Return
OCM
Orleans Capital Management Mandeville, Louisiana $148M AUM 24.31% 1-Year Est. Return
CWMS
Cannon Wealth Management Services Winston Salem, North Carolina $148M AUM 13.37% 1-Year Est. Return
FFS
Flavin Financial Services Melbourne, Florida $149M AUM 14.79% 1-Year Est. Return
KCM
KM Capital Management Austin, Texas $149M AUM 18.7% 1-Year Est. Return
DAC
Dutch Asset Corp Selkirk, New York $149M AUM
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Peapod Lane Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Peapod Lane Capital held 68 positions worth $122M, up 3.7% from $118M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Peapod Lane Capital's Q1 2026 filing shows 9 new, 32 increased, 20 reduced and 6 closed positions. Its largest new stake was Standard BioTools: 2,028,527 shares worth $1.86M. The largest sale was iShares Russell 2000 ETF, an estimated $4.86M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Peapod Lane Capital's largest Q1 2026 buy was Standard BioTools: 2,028,527 shares worth $1.86M.
  • Peapod Lane Capital added most to Arq in Q1 2026, an estimated $1.75M increase.
  • Peapod Lane Capital's biggest Q1 2026 reduction was Alto Ingredients, cutting an estimated $2.66M.
  • Peapod Lane Capital fully exited iShares Russell 2000 ETF in Q1 2026, selling an estimated $4.86M.
  • Peapod Lane Capital's ten largest holdings make up 31% of its $122M portfolio in Q1 2026.
  • Peapod Lane Capital opened 9 new positions and closed 6 in Q1 2026.
  • Peapod Lane Capital's portfolio value rose 3.7% quarter-over-quarter to $122M.

Based on Peapod Lane Capital's 13F filing for Q1 2026, filed 4 May 2026.